Literature DB >> 35674383

Advancing translational neuroscience research for eating disorders.

Claire J Foldi1,2, Morgan H James3,4, Robyn M Brown5,6, Milan K Piya7,8, Trevor Steward9,10.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35674383      PMCID： PMC9248015          DOI： 10.1177/00048674221106678

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN： 0004-8674            Impact factor:   5.598


× No keyword cloud information.
  6 in total

1.  When illness severity and research dollars do not align: are we overlooking eating disorders?

Authors:  Stuart B Murray; Eva Pila; Scott Griffiths; Daniel Le Grange
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

Review 2.  A review of sex differences in the mechanisms and drivers of overeating.

Authors:  R G Anversa; M Muthmainah; D Sketriene; A Gogos; P Sumithran; R M Brown
Journal:  Front Neuroendocrinol       Date:  2021-08-26       Impact factor: 8.606

Review 3.  Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.

Authors:  Daniel J Drucker
Journal:  Cell Metab       Date:  2018-04-03       Impact factor: 27.287

Review 4.  Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link.

Authors:  Jacqueline B Mehr; Deborah Mitchison; Hannah E Bowrey; Morgan H James
Journal:  Neuropsychopharmacology       Date:  2021-06-18       Impact factor: 7.853

5.  Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Authors:  R L Carhart-Harris; M Bolstridge; C M J Day; J Rucker; R Watts; D E Erritzoe; M Kaelen; B Giribaldi; M Bloomfield; S Pilling; J A Rickard; B Forbes; A Feilding; D Taylor; H V Curran; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  2017-11-08       Impact factor: 4.530

6.  Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.

Authors:  Manoj K Doss; Michal Považan; Monica D Rosenberg; Nathan D Sepeda; Alan K Davis; Patrick H Finan; Gwenn S Smith; James J Pekar; Peter B Barker; Roland R Griffiths; Frederick S Barrett
Journal:  Transl Psychiatry       Date:  2021-11-08       Impact factor: 6.222
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.